Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Stroke. 2014 Jan 14;45(3):828–834. doi: 10.1161/STROKEAHA.113.003754

Fig 6. SD208 attenuates GMH-induced accumulation of GFAP and vitronectin.

Fig 6

GMH increased accumulation of (A) GFAP and (B) vitronectin. SD208 attenuated GMH-induced deposition of GFAP at day 10 (A) and vitronectin at day 24 (B).